跳至主要内容
临床试验/ITMCTR2000003188
ITMCTR2000003188尚未招募1 期

Development and application of TCM body regulating protection scheme for the convalescent population of novel coronavirus pneumonia (COVID-19)

Beijing University of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 70(—)
性别
All

入选标准

  • 1. Meet the history of COVID-19 confirmed in accordance with the diagnosis and treatment plan of COVID-19(trial seventh edition);
  • 2. Meet the discharge standards of COVID-19(trial seventh edition);
  • 3. Meet the diagnosis standard of qi deficiency and phlegm stasis syndrome;
  • 4. Patients aged 18-70 years old, 28 days after discharge, still have abnormal manifestations on lung CT;
  • 5. Patients willing to sign informed consent.

排除标准

  • 1. Patients with primary and secondary cardiovascular, cerebrovascular, renal, endocrine, neurological and blood system diseases, tumors and tuberculosis;
  • 2. Patients who have participated in or are participating in other clinical trials within one month;
  • 3. Patients with mental disorders who can not express their feelings;
  • 4. There are other situations that are not suitable to be included in the study.

研究者

发起方
Beijing University of Chinese Medicine

相似试验